Block-replacement Therapy During Radioiodine Therapy
NCT00150124
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Toxic Nodular Goitre
Graves' Disease
Interventions
DRUG:
MTZ+LT4
DRUG:
Methimazole
Sponsor
Steen Bonnema